Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke

Table 4 Binary and multiple linear regression for predicting mortality and three-month mRS based on ALP/ALT ratio

	Three-month mortality^*				Three-month mRS
Variable	Odds ratio	SE	95% C.I. for OR	P-value	Standardized Coefficients B	95% C.I. for B	P-value	Adjusted R square
Age	1.07	0.01	1.04 -1.09	< 0.001	0.359	0.04-0.07	< 0.001
Gender	0.93	0.30	0.52-1.68	0.826	0.020	−0.40-0.57	0.738
Underlying Disease	1.46	0.29	0.82-2.60	0.189	0.006	−0.45-0.50	0.910
History of smoking	6.41	0.34	3.24-12.68	< 0.001	0.262	0.69-1.75	< 0.001
ALP/ALT	0.97	0.02	0.93-1.01	0.251	0.014	−0.03-0.04	0.811
Model summary								0.19

ALP alkaline phosphatase, ALT alanine transaminase, mRS modified Rankin Scale, C.I. confidence interval, SE standard error, OR odds ratio
^*Residuals were tested for normality using Q-Q-plot (Fig. 3). P-value< 0.05 is statistically significant

ISSN: 1471-2377